Business

Dexcom Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 at 4:30 p.m. Eastern Time

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2021 financial results after market close

articleDexcom, Inc.October 5, 20213/company/dexcom-inc/news/dexcom-schedules-third-quarter-2021-earnings-release-and-conference-call-for-october-28-2021-at-430-pm-eastern-time
Dexcom Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 at 4:30 p.m. Eastern Time

About this update from Dexcom, Inc.

[{"type":"text","content":" SAN DIEGO--(BUSINESS WIRE)--\nDexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2021 financial results after market close on Thursday, October 28, 2021. Management will hold a conference call to review the company's third quarter 2021 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be archived there for future reference.\n\nTo listen to the conference call, please dial (800) 446-1671 (US/Canada) or (847) 413-3362 (International) and use the confirmation number \"49591484\" approximately five minutes prior to the start time.\n\nAbout DexCom, Inc.\n\nDexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20211005005462/en/\n\nDexCom, Inc.:\nSean Christensen\nSenior Director – Investor Relations and Corporate Financial Planning & Analysis\[email protected]\n(858) 200-0200\n\nSource: Dexcom, Inc.","length":3244,"tagName":"div"}]

More updates from Dexcom, Inc.